Many firms on back foot due to US regulatory woes

It has been a mixed bag in terms of performance of pharma stocks in the last one year. Jubilant Life, Biocon and Caplin Point Lab gave top returns; up by 118 per cent, 104...
obama care

Expectations of hike in healthcare spending

Obamacare may have split opinion in the US right down the middle leading to the insurance programme being abandoned by US President Donald Trump. But with health barely featuring in election campaigns in India, the...

Granules to invest $20 mn in US subsidiary, Q3 net up 34% at Rs....

The company Board of Granules India Ltd has announced its move to invest $20 million in its wholly-owned subsidiary Granules Pharmaceulticals Inc. The company registered a net profit of Rs. 39 crore during the third quarter ended...